Loading…
Held by equity mutual funds in 2 disclosed months, Aug 2026 to Sep 2026.
Symbiotec Pharmalab Limited (Pharmaceuticals & Biotechnology) was held by 19 active equity mutual funds in September 2026, ₹397 Cr in all (down 13 funds from Aug 2026). The largest position was Baroda BNP Paribas Focused Fund at 2.3% of its portfolio. During the month 7 funds entered and 20 exited. Funds have disclosed holding it since Aug 2026.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.
None.